Results strongly support continued development of Cytoki's oral IL-22 program for UC which is part of its growing preclinical pipeline of IL-22-based assets SØBORG, Denmark, May 8, 2025 /PRNewswire/ - ...
Inflammatory bowel disease, in which the immune system attacks the gut, is a painful chronic condition that affects three million Americans. Rates of IBD are rising, and there’s currently no cure. IBD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results